LY4167586

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4167586, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy [Phase 1]